New Results
Neuronopathic GBA1 L444P mutation accelerates Glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions
View ORCID ProfileCasey L. Mahoney-Crane, View ORCID ProfileMegha Viswanathan, Dreson Russell, Rachel A.C. Curtiss, View ORCID ProfileJennifer Freire, Sai Sumedha Bobba, Sean D. Coyle, Monika Kandebo, Lihang Yao, Bang-Lin Wan, View ORCID ProfileNathan G. Hatcher, Sean M. Smith, Jacob N. Marcus, View ORCID ProfileLaura A. Volpicelli-Daley
doi: https://doi.org/10.1101/2022.04.07.487391
Casey L. Mahoney-Crane
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Megha Viswanathan
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Dreson Russell
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Rachel A.C. Curtiss
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Jennifer Freire
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Sai Sumedha Bobba
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Sean D. Coyle
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Monika Kandebo
2Neuroscience Discovery, Merck & Co., Inc., West Point, PA, USA 19486
Lihang Yao
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Bang-Lin Wan
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Nathan G. Hatcher
2Neuroscience Discovery, Merck & Co., Inc., West Point, PA, USA 19486
Sean M. Smith
2Neuroscience Discovery, Merck & Co., Inc., West Point, PA, USA 19486
Jacob N. Marcus
2Neuroscience Discovery, Merck & Co., Inc., West Point, PA, USA 19486
Laura A. Volpicelli-Daley
1Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL, USA 35294
Ph.D
Posted April 08, 2022.
Neuronopathic GBA1 L444P mutation accelerates Glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, Dreson Russell, Rachel A.C. Curtiss, Jennifer Freire, Sai Sumedha Bobba, Sean D. Coyle, Monika Kandebo, Lihang Yao, Bang-Lin Wan, Nathan G. Hatcher, Sean M. Smith, Jacob N. Marcus, Laura A. Volpicelli-Daley
bioRxiv 2022.04.07.487391; doi: https://doi.org/10.1101/2022.04.07.487391
Neuronopathic GBA1 L444P mutation accelerates Glucosylsphingosine levels and formation of hippocampal alpha-synuclein inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, Dreson Russell, Rachel A.C. Curtiss, Jennifer Freire, Sai Sumedha Bobba, Sean D. Coyle, Monika Kandebo, Lihang Yao, Bang-Lin Wan, Nathan G. Hatcher, Sean M. Smith, Jacob N. Marcus, Laura A. Volpicelli-Daley
bioRxiv 2022.04.07.487391; doi: https://doi.org/10.1101/2022.04.07.487391
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)